Cory R. Trankle

Cardiology

9000 Stony Pkwy
Richmond, VA 23235

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 111 publications

INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED WITH ANAKINRA.

INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED WITH ANAKINRA.

Journal: Journal of cardiovascular pharmacology

Published: July 15, 2026

INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED WITH ANAKINRA.

INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED WITH ANAKINRA.

Journal: medRxiv : the preprint server for health sciences

Published: May 04, 2026

Incremental Prognostic Value of Cardiac Magnetic Resonance Beyond Biomarker Staging in Transthyretin Cardiac Amyloidosis.

Incremental Prognostic Value of Cardiac Magnetic Resonance Beyond Biomarker Staging in Transthyretin Cardiac Amyloidosis.

Journal: European heart journal. Cardiovascular Imaging

Published: March 04, 2026

Incremental prognostic value of cardiac magnetic resonance beyond biomarker staging in transthyretin cardiac amyloidosis.

Incremental prognostic value of cardiac magnetic resonance beyond biomarker staging in transthyretin cardiac amyloidosis.

Journal: European heart journal. Cardiovascular Imaging

Published: March 04, 2026

Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis.

Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis.

Journal: Circulation

Published: February 06, 2026

Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy.

Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy.

Journal: The American journal of cardiology

Published: January 26, 2026

Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy.

Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy.

Journal: The American journal of cardiology

Published: January 26, 2026

Synthetic Contrast-Free LGE in Acute MI: Assessing the Promise and Boundaries of Diffusion-Based Modeling.

Synthetic Contrast-Free LGE in Acute MI: Assessing the Promise and Boundaries of Diffusion-Based Modeling.

Journal: Circulation. Cardiovascular imaging

Published: January 23, 2026

Prognostic utility of the MECKI score in a mixed United States cohort.

Prognostic utility of the MECKI score in a mixed United States cohort.

Journal: Physiological reports

Published: January 09, 2026

Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by Anakinra.

Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by Anakinra.

Journal: Circulation. Heart failure

Published: December 23, 2025

Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by Anakinra.

Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by Anakinra.

Journal: Circulation. Heart failure

Published: December 23, 2025

Nephrogenic Systemic Fibrosis in Patients with Advanced Renal Dysfunction Following Gadolinium-based Contrast Agents.

Nephrogenic Systemic Fibrosis in Patients with Advanced Renal Dysfunction Following Gadolinium-based Contrast Agents.

Journal: Radiology

Published: December 16, 2025

Showing 1-12 of 111

Last Updated: 09/26/2026